Watchlist Price Alert

Lexeo Therapeutics Inc. C... (LXEO)

NASDAQ: LXEO · Real-Time Price · USD

3.95

0.01 (0.25%)

At close: Jun 16, 2025, 3:59 PM

3.90

-1.27%

After-hours: Jun 16, 2025, 07:56 PM EDT

Lexeo Therapeutics Common Stock Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022
Net Income	-109.31M	-98.33M	-86.6M	-77.22M	-69.42M	-66.39M	-66.78M	-63.73M	-65.43M	-59.28M	-44.7M	-27.64M	-12.5M
Depreciation & Amortization	346K	750K	719K	1.92M	1.87M	1.84M	1.8M	1.68M	1.59M	1.15M	700K	358K	6.7K
Stock-Based Compensation	13.84M	12.47M	9.77M	6.85M	4.98M	3.04M	2.76M	2.32M	1.35M	952K	431K	n/a	n/a
Other Working Capital	-10.57M	-8.79M	-6.16M	2.58M	6.64M	1.66M	1.61M	1.84M	3.45M	2.27M	4.07M	-428K	-2.78M
Other Non-Cash Items	10.38M	10.37M	10.65M	530K	530K	530K	272K	n/a	554.11K	828.83K	828.83K	828.83K	274.72K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-3.69M	-6.41M	-1.35M	4.96M	6.05M	1.48M	-187K	-248K	4.1M	1.79M	4.81M	313K	-2.87M
Operating Cash Flow	-88M	-81.15M	-66.81M	-62.95M	-55.99M	-59.5M	-62.14M	-59.98M	-57.84M	-54.56M	-37.93M	-26.14M	-15.09M
Capital Expenditures	-275K	-468K	-554K	-537K	-358K	-165K	-199K	-546K	-727.38K	-901K	-794K	-394K	-173.63K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	15.6M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	-93.6M	-93.61M	-26K	-63K	-58K	-50K	-132K	-126K	-126K	-126K	-44K	n/a	n/a
Investing Cash Flow	-78.28M	-94.08M	-567K	-537K	-358K	-165K	-199K	-546K	-727.38K	-901K	-794K	-394K	-173.63K
Debt Repayment	-460K	-410K	-399K	3.6M	3.58M	3.58M	3.57M	-357K	-254K	-144K	-36K	n/a	n/a
Common Stock Repurchased	-4K	-4K	n/a	-13K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	481K	491K	100.64M	100.62M	100.21M	100.22M	68K	49K	89.01K	333K	305K	305K	255.99K
Financial Cash Flow	133K	88.78M	188.94M	192.93M	192.54M	103.79M	3.64M	-308K	-164.99K	189K	270K	305K	255.99K
Net Cash Flow	-162.9M	-83.2M	124.82M	132.69M	136.2M	44.13M	-58.7M	-64.09M	-58.73M	-55.27M	-38.46M	-26.23M	-15.01M
Free Cash Flow	-88.28M	-81.62M	-67.36M	-63.49M	-56.35M	-59.66M	-62.34M	-60.53M	-58.57M	-55.46M	-38.73M	-26.54M	-15.27M